STOCK TITAN

[Form 4] Cencora, Inc. Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4

Elizabeth S. Campbell, Executive Vice President and director of Cencora, Inc. (COR), reported a sale of 1,886 shares of Cencora common stock on 10/01/2025 at a price of $313.28 per share. Following the transaction, the reporting person beneficially owned 12,824.141 shares. The Form 4 states the sale was executed under a Rule 10b5-1 trading plan adopted on 12/20/2024. The form is signed by Ms. Campbell on 10/03/2025.

Elizabeth S. Campbell, vicepresidente esecutivo e direttore di Cencora, Inc. (COR), ha riportato una vendita di 1.886 azioni ordinarie di Cencora in data 01/10/2025 a un prezzo di $313,28 per azione. Dopo la transazione, la persona segnalante possedeva beneficiariamente 12.824,141 azioni. Il modulo 4 indica che la vendita è stata eseguita secondo un piano di negoziazione 10b5-1 adottato il 20/12/2024. Il modulo è firmato dalla signora Campbell il 03/10/2025.

Elizabeth S. Campbell, vicepresidenta Ejecutiva y directora de Cencora, Inc. (COR), reportó la venta de 1.886 acciones ordinarias de Cencora el 01/10/2025 a un precio de $313,28 por acción. Tras la transacción, la persona reportante poseía beneficiosamente 12.824,141 acciones. El Formulario 4 indica que la venta se realizó bajo un plan de negociación 10b5-1 adoptado el 20/12/2024. El formulario está firmado por la Sra. Campbell el 03/10/2025.

Elizabeth S. Campbell은(는) Cencora, Inc. (COR)의 상무부사장 겸 이사로서 1,886주(Cencora 보통주) 매도를 2025-10-01에 주당 $313.28의 가격으로 보고했습니다. 거래 후 보고자는 실질적으로 12,824.141주를 소유했습니다. Form 4에 따르면 매도는 10b5-1 규칙에 따른 거래 계획에 따라 실행되었으며, 이 계획은 2024-12-20에 채택되었습니다. 양식은 캠벨 여사가 2025-10-03에 서명했습니다.

Elizabeth S. Campbell, vice-présidente exécutive et administratrice de Cencora, Inc. (COR), a annoncé la vente de 1 886 actions ordinaires de Cencora le 01/10/2025 au prix de $313,28 par action. Suite à la transaction, la personne déclarant détenait bénéficiairement 12 824,141 actions. Le formulaire 4 indique que la vente a été réalisée dans le cadre d'un plan de négociation 10b5-1 adopté le 20/12/2024. Le formulaire est signé par Mme Campbell le 03/10/2025.

Elizabeth S. Campbell, Executive Vice President und Direktorin von Cencora, Inc. (COR), meldete den Verkauf von 1.886 Stammaktien von Cencora am 01.10.2025 zu einem Preis von $313,28 pro Aktie. Nach der Transaktion besaß die meldende Person wirtschaftlich 12.824,141 Aktien. Das Formular 4 gibt an, dass der Verkauf im Rahmen eines 10b5-1-Handelsplans erfolgte, der am 20.12.2024 angenommen wurde. Das Formular ist von Frau Campbell am 03.10.2025 unterschrieben.

Elizabeth S. Campbell، نائبة الرئيس التنفيذي ومديرة Cencora, Inc. (COR)، أعلنت عن بيع 1,886 سهمًا من أسهم Cencora العادية في 01/10/2025 بسعر $313.28 للسهم الواحد. عقب الصفقة، امتلكت الشخص المبلّغ عنه beneficiariamente 12,824.141 سهمًا. يذكر النموذج 4 أن البيع تم بموجب خطة تداول 10b5-1 المعتمدة في 20/12/2024. النموذج موقع من السيدة Campbell في 03/10/2025.

Elizabeth S. Campbell,Cencora, Inc. (COR) 的执行副总裁兼董事宣布在 2025/10/01 以每股 $313.28 的价格出售了 1,886 股 Cencora 普通股。交易后,申报人实际持有 12,824.141 股。Form 4 表明此次出售是在 10b5-1 交易计划下执行,该计划于 2024/12/20 批准。表格由 Campbell 女士于 2025/10/03 签署。

Positive
  • None.
Negative
  • None.

Insights

Analyzing...

Elizabeth S. Campbell, vicepresidente esecutivo e direttore di Cencora, Inc. (COR), ha riportato una vendita di 1.886 azioni ordinarie di Cencora in data 01/10/2025 a un prezzo di $313,28 per azione. Dopo la transazione, la persona segnalante possedeva beneficiariamente 12.824,141 azioni. Il modulo 4 indica che la vendita è stata eseguita secondo un piano di negoziazione 10b5-1 adottato il 20/12/2024. Il modulo è firmato dalla signora Campbell il 03/10/2025.

Elizabeth S. Campbell, vicepresidenta Ejecutiva y directora de Cencora, Inc. (COR), reportó la venta de 1.886 acciones ordinarias de Cencora el 01/10/2025 a un precio de $313,28 por acción. Tras la transacción, la persona reportante poseía beneficiosamente 12.824,141 acciones. El Formulario 4 indica que la venta se realizó bajo un plan de negociación 10b5-1 adoptado el 20/12/2024. El formulario está firmado por la Sra. Campbell el 03/10/2025.

Elizabeth S. Campbell은(는) Cencora, Inc. (COR)의 상무부사장 겸 이사로서 1,886주(Cencora 보통주) 매도를 2025-10-01에 주당 $313.28의 가격으로 보고했습니다. 거래 후 보고자는 실질적으로 12,824.141주를 소유했습니다. Form 4에 따르면 매도는 10b5-1 규칙에 따른 거래 계획에 따라 실행되었으며, 이 계획은 2024-12-20에 채택되었습니다. 양식은 캠벨 여사가 2025-10-03에 서명했습니다.

Elizabeth S. Campbell, vice-présidente exécutive et administratrice de Cencora, Inc. (COR), a annoncé la vente de 1 886 actions ordinaires de Cencora le 01/10/2025 au prix de $313,28 par action. Suite à la transaction, la personne déclarant détenait bénéficiairement 12 824,141 actions. Le formulaire 4 indique que la vente a été réalisée dans le cadre d'un plan de négociation 10b5-1 adopté le 20/12/2024. Le formulaire est signé par Mme Campbell le 03/10/2025.

Elizabeth S. Campbell, Executive Vice President und Direktorin von Cencora, Inc. (COR), meldete den Verkauf von 1.886 Stammaktien von Cencora am 01.10.2025 zu einem Preis von $313,28 pro Aktie. Nach der Transaktion besaß die meldende Person wirtschaftlich 12.824,141 Aktien. Das Formular 4 gibt an, dass der Verkauf im Rahmen eines 10b5-1-Handelsplans erfolgte, der am 20.12.2024 angenommen wurde. Das Formular ist von Frau Campbell am 03.10.2025 unterschrieben.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Campbell Elizabeth S

(Last) (First) (Middle)
1 WEST FIRST AVENUE

(Street)
CONSHOHOCKEN PA 19428

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Cencora, Inc. [ COR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Executive Vice President
3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/01/2025 S 1,886(1) D $313.28 12,824.141 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/20/2024.
Remarks:
/s/ Elizabeth S. Campbell 10/03/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Elizabeth S. Campbell report on Form 4 for Cencora (COR)?

The Form 4 reports a sale of 1,886 shares of Cencora common stock on 10/01/2025 at $313.28 per share.

How many Cencora shares does the reporting person own after the sale?

After the reported transaction the reporting person beneficially owned 12,824.141 shares.

Was the sale part of a trading plan?

Yes. The Form 4 states the sale was effected pursuant to a Rule 10b5-1 trading plan adopted on 12/20/2024.

When was the Form 4 signed and filed?

The signature on the Form 4 is dated 10/03/2025.

What is the reporting person’s role at Cencora?

The reporting person, Elizabeth S. Campbell, is listed as an Executive Vice President and a Director.
Cencora Inc.

NYSE:COR

COR Rankings

COR Latest News

COR Latest SEC Filings

COR Stock Data

58.70B
185.75M
4.2%
94.03%
3.17%
Medical Distribution
Wholesale-drugs, Proprietaries & Druggists' Sundries
Link
United States
CONSHOHOCKEN